Zhengye Biotechnology Holding Limited Ordinary Shares Cash Flow Quality Index
Zhengye Biotechnology Holding Limited Ordinary Shares cash flow quality index. Zhengye Biotechnology Holding Limited Ordinary Shares (ZYBT) has a Cash Flow Quality Index of 3.05x as of December 2025. Operating cash flow of $41.05 Million exceeds net income of $13.47 Million, indicating high earnings quality where cash backs reported profits. See Zhengye Biotechnology Holding Limited Or financial flexibility index to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Zhengye Biotechnology Holding Limited Ordinary Shares (2021–2025)
Cash flow quality index of Zhengye Biotechnology Holding Limited Ordinary Shares from 2021 to 2025. Historical Cash Flow Quality Index for Zhengye Biotechnology Holding Limited Ordinary Shares across 5 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore Zhengye Biotechnology Holding Limited Or cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Zhengye Biotechnology Holding Limited Ordinary Shares Cash Flow Quality Index by Year (2021–2025)
Zhengye Biotechnology Holding Limited Ordinary Shares cash flow quality index by year from 2021 to 2025. Year-by-year earnings quality comparison for Zhengye Biotechnology Holding Limited Ordinary Shares. For the full cash flow conversion analysis, see ZYBT operating cash flow.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 3.05x | $41.05 Million | $13.47 Million | ▼ -16.0% |
| 2024 | 3.63x | $41.05 Million | $11.31 Million | ▲ +182.5% |
| 2023 | 1.28x | $48.18 Million | $37.51 Million | ▲ +313.1% |
| 2022 | 0.31x | $17.34 Million | $55.74 Million | ▼ -54.6% |
| 2021 | 0.68x | $31.81 Million | $46.47 Million | — |